T2 Biosystems, Inc.·4

Mar 28, 4:02 PM ET

Gibbs Michael Terrence 4

4 · T2 Biosystems, Inc. · Filed Mar 28, 2023

Insider Transaction Report

Form 4
Period: 2023-03-24
Gibbs Michael Terrence
General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2023-03-24+3336,850 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-03-243330 total
    Common Stock (333 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On March 24, 2020 the reporting person was granted 1,000 RSU's that vest in three equal annual installments commencing on March 24, 2021.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4